Pharma & Biotech

Pharmaceutical titan Eli Lilly has delivered significant news on two distinct fronts, capturing investor attention. Beyond the intense spotlight on...

The disconnect between a company's operational performance and its stock market valuation is rarely as stark as the current situation...

Investors in Redcare Pharmacy are witnessing a severe disconnect. While the company's operational performance shows robust growth, its equity value...

The intersection of quantum computing and healthcare is drawing a skeptical eye from investors. IonQ, a leader in developing commercial...

ResMed's stock is experiencing notable selling pressure in today's trading session. This movement follows a significant shift in sentiment from...

A dramatic intraday sell-off in Assembly Biosciences shares, followed by a partial recovery, has highlighted a sharp divide in the...

Pharmaceutical titan Pfizer finds itself at a pivotal juncture. The era of spectacular pandemic-driven profits is receding, and the company...

Investors in Ocugen, a biotechnology firm focused on genetic treatments for rare eye diseases, were met with unsettling news in...

The clinical-stage biopharmaceutical company Annexon, Inc. is currently riding a significant wave of positive analyst coverage. In a concentrated period,...

Shares of Galectin Therapeutics declined for a third consecutive trading day on Tuesday, closing at $5.46. The session's loss amounted...